Allscripts Clients Showcase the Power and Potential of Next-Generation Solutions
CHICAGO, June 21, 2013 /PRNewswire/ — In an industry focused primarily on discrete healthcare solutions, Allscripts (NASDAQ: MDRX), in partnership with lead clients, is defining the next generation of Population Health Management solutions.
At a gathering of financial and industry analysts at the Center for Connected Medicine (CCM) in Pittsburgh on Tuesday, Allscripts President and Chief Executive Officer Paul Black outlined the company’s strategy, powered by dbMotion and its patient portal FollowMyHealth™, for the future of Population Health Management. As part of this, Allscripts intends to be a catalyst to move the industry from a fee-for-service approach to healthcare to a value-based care approach, which focuses on clients’ needs for reduced healthcare costs, improved health outcomes and improved quality outcomes.
Demonstrating real solutions in action, Dr. Rasu Shrestha, Vice President, Medical Information Technology at UPMC, a founding member of the CCM, and John Glynn, Senior Vice President and Chief Information Officer with Unity Health System, shared examples of how Allscripts technology, analytics and population health solutions are helping them improve healthcare and community treatment protocols at their respective organizations. A replay of the presentations is available on the Investor Relations page of allscripts.com here.
“We are at a tipping point in the industry,” Black said. “We are beginning to see tremendous pull through from patients, clinicians and hospitals for the kinds of rich informatics and insights enabled by open solutions geared toward keeping patients healthy and reducing overall cost. We look at Population Health Management in three dimensions: enabling innovation and technology solutions on an open, community-wide platform, partnering with clients to ensure rapid adoption, and supporting the fundamental redesign in care enabled by Population Health Management.”
Building on the momentum from its recent Population Health Forum in Pittsburgh – where caregivers shared their perspectives about the next generation of Population Health Management capabilities – Allscripts is also engaging in discussions with the CEOs of some of the nation’s most innovative caregivers who share Allscripts vision for Population Health Management, and together they are setting the stage for a new level of collaboration.
The Center for Connected Medicine is the world’s first collaborative health care executive briefing center, supporting stakeholders in defining the transformation of health care. It serves as a resource for innovative patient-centered and population health models, showcasing strategically integrated health information technology. Established in 2009 and located in Pittsburgh, the Center for Connected Medicine is comprised of five founding partners—Alcatel Lucent, GE, IBM, UPMC and Verizon—and a group of strategic partners representing various facets of the health information community. By facilitating connections among those who deliver, receive and support health care, the Center helps promote cultural change, coordinated care delivery and greater patient engagement. To learn more about connected medicine, as well as the Center’s vision and initiatives, please visit www.connectedmed.com.
Allscripts (NASDAQ: MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company’s Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a Connected Community of Health™ for physicians, hospitals and post-acute organizations. To learn more about Allscripts, please visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2013 Allscripts Healthcare, LLC. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are either registered trademarks or trademarks of Allscripts Healthcare, LLC in the United States and/or other countries. All other trademarks are the property of their respective owners.
This press release contains forward-looking statements within the meaning of the federal securities laws. Statements regarding future events or developments, our future performance, as well as management’s expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements with the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on our results of operations or financial condition. Such risks, uncertainties and other factors include, among other things: the possibility that our current initiatives focused on product delivery, client experience, streamlining our cost structure, and financial performance may not be successful, which could result in customer attrition; the impact of the realignment of our sales and services organization; potential difficulties or delays in achieving platform and product integration and the connection and movement of data among hospitals, physicians, patients and others; the risk that we will not achieve the strategic benefits of the merger (the “Eclipsys Merger”) with Eclipsys Corporation (Eclipsys), or other companies that we have purchased or that the Allscripts products will not be integrated successfully with these other companies products; competition within the industries in which we operate, including the risk that existing clients will switch to products of competitors; failure to maintain interoperability certification pursuant to the Health Information Technology for Economic and Clinical Health Act, with resulting increases in development and other costs for us and possibly putting us at a competitive disadvantage in the marketplace; the volume and timing of systems sales and installations, the length of sales cycles and the installation process and the possibility that our products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; we may incur costs or customer losses relating to the standardization of our small office electronic health record and practice management systems that could adversely affect our results of operations; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; errors or similar problems in our software products or other product quality issues; the outcome of any legal proceeding that has been or may be instituted against us and others; compliance obligations under new and existing laws, regulations and industry initiatives, including new regulations relating to HIPAA/HITECH, increasing enforcement activity in respect of anti-bribery, fraud and abuse, privacy, and similar laws, and future changes in laws or regulations in the healthcare industry, including possible regulation of our software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; the continued implementation and ongoing acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009, as well as elements of the Patient Protection and Affordable Care Act (aka health reform) which pertain to healthcare IT adoption, including uncertainly related to changes in reimbursement methodology and the shift to pay-for-outcomes; maintaining our intellectual property rights and litigation involving intellectual property rights; legislative, regulatory and economic developments; risks related to third-party suppliers and our ability to obtain, use or successfully integrate third-party licensed technology; breach of data security by third parties and unauthorized access to patient health information by third parties resulting in enforcement actions, fines and other litigation. See our Annual Report on Form 10-K/10K-A for 2012 and other public filings with the SEC for a further discussion of these and other risks and uncertainties applicable to our business. The statements herein speak only as of their date and we undertake no duty to update any forward-looking statement whether as a result of new information, future events or changes in expectations.
SOURCE Allscripts Healthcare Solutions, Inc.
Investors: Seth Frank, 312-506-1213, email@example.com or Media: Claire Weingarden, 312-447-2442, firstname.lastname@example.org